These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3260320

  • 1. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F, Meller E.
    Brain Res; 1989 Dec 18; 504(2):276-83. PubMed ID: 2574622
    [Abstract] [Full Text] [Related]

  • 7. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R, Spina L, Di Chiara G.
    Life Sci; 1987 Nov 02; 41(18):2135-45. PubMed ID: 2959833
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E, Caporali MG.
    Neuropharmacology; 1987 Apr 02; 26(4):355-60. PubMed ID: 2953987
    [Abstract] [Full Text] [Related]

  • 9. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 02; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 10. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 02; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 11. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 02; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 12. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 02; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan 02; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 14. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R, Gandolfi O, Vaccheri A, Roncada P, Montanaro N.
    Psychopharmacology (Berl); 1988 Jan 02; 95(3):381-5. PubMed ID: 2901128
    [Abstract] [Full Text] [Related]

  • 15. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS, Jones DN, Holtzman SG, Juncos JL, Kalivas PW, Justice JB.
    Psychopharmacology (Berl); 1994 Oct 02; 116(2):217-25. PubMed ID: 7862951
    [Abstract] [Full Text] [Related]

  • 16. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O, Dall'olio R, Vaccheri A, Roncada P, Montanaro N.
    Pharmacol Biochem Behav; 1988 Jun 02; 30(2):463-9. PubMed ID: 3262877
    [Abstract] [Full Text] [Related]

  • 17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 18. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 10; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 20. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM, Cereska KS.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr 10; 339(4):383-6. PubMed ID: 2567965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.